Healthcare
We create and invest in leading companies in therapeutics, medtech, and health IT & services.
33
Thirty three products and drugs approved
With another 12 drugs in phase 3. Typically, only 1 in 5,000 drugs makes it from idea to market.
30+
Over thirty companies created from scratch
If we can't find a company solving an important problem, we create one ourselves - just like we did with Innovent, Denali, Beam and Prime Medicine to name a few.
$3.5B
Over three and a half billion dollars over eleven funds
Without the pressure of fundraising from outside investors, we're privileged to champion companies that help heal the world.
Category
-
News Direct
Doceree launches industry-first HCP-focused global DSP for media agencies at Cannes Lions 2023
June 19, 2023 -
GenomeWeb
With $50M Investment in MOSAIC Project, Owkin Seeks to Become Cancer ‘Drug Discovery Enterprise’
June 16, 2023 -
Eleos Health
Eleos Health Partners with Trilogy, Adds COO to Customer Advisory Board
June 14, 2023 -
Accesswire
Owkin Rolls Out Its Landmark AI Diagnostic Within Medipath, the Largest Network of Pathologists in France
June 14, 2023 -
Business Wire
Wedgewood Pharmacy Merges with Blue Rabbit to Deliver Exceptional Veterinary Pharmacy Services Nationwide
June 14, 2023 -
Behavioral Health Business
BHB Value: The Pursuit of High Quality Applied Behavior Analysis
June 13, 2023 -
PR Newswire
Comanche Biopharma Strengthens Board of Directors with Appointment of Dr. Ann Taylor
June 13, 2023 -
Drug Target Review
Game-changing pan-TEAD inhibitor for solid tumours
June 12, 2023 -
Business Insider
The fertility business is booming as startups go after big profits in a $54 billion market, even as other healthcare companies slump
June 12, 2023 -
Globenewswire
Pulmocide Announces Expansion of Management Team
June 8, 2023 -
PR Newswire
Equip Partnership Adds Eating Disorder Support to Accolade’s Trusted Partner Ecosystem
June 7, 2023 -
USA Today
Pregnant and over 40? You aren’t alone. More women are becoming later-in-life moms.
June 7, 2023 -
PR Newswire
Benchling Delivers an Integrated R&D Ecosystem with New Product Offerings
June 6, 2023 -
Endpoints News
Early data show Bicara’s bispecific helps shrink head and neck cancers when combined with Keytruda: #ASCO23
June 5, 2023 -
Business Wire
Bicara Therapeutics’ First-in-class Bifunctional EGFR/TGF-β Inhibitor, BCA101, Demonstrates 65% ORR in Combination with Pembrolizumab in 1L HPV-negative Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC)
June 5, 2023 -
BioWorld
Insilico Medicine describes new USP1 inhibitors for cancer
June 2, 2023 -
Boston Business Journal
Long-term optimism, but short-term worry among Mass. biotech VCs
June 2, 2023 -
Pharmabiz
PlasmaGen Biosciences to invest in Karnataka for advanced blood plasma production unit
June 2, 2023 -
PR Newswire
WelbeHealth Continues Los Angeles Expansion With Opening of New PACE Centers in Rosemead and North Hollywood
June 1, 2023 -
BioWorld
Insilico Medicine divulges new 3CLpro inhibitors for SARS-CoV-2
June 1, 2023 -
PR Newswire
TraceLink Ensures DSCSA Verification Readiness and End-to-End VRS Support for Pharmaceutical Supply Chain Members Amid Vendor Turbulence
June 1, 2023 -
Business Wire
Owkin Powers a New Era in Oncology Research with MOSAIC – An Unprecedented $50 Million Spatial Atlas of Cancer Cells
June 1, 2023 -
Pharmabiz
Lupin collaborates with Enzene Biosciences to launch Cetuximab in India to treat head and neck cancer
May 30, 2023 -
PR Newswire
PlasmaGen Biosciences opens new manufacturing facility for blood plasma products in Kolar
May 30, 2023 -
PR Newswire
ABK Biomedical Announces FDA IDE Approval for a Multi-Center Pivotal Study of Eye90 microspheres® in Hepatocellular Carcinoma
May 30, 2023 -
Newswire
Protenus Selected as One of the 2023 Best Places to Work in Healthcare
May 30, 2023 -
Financial Express
Enzene Biosciences launches first biosimilar of Cancer treatment drug Erbitux
May 29, 2023 -
Globenewswire
Structure Therapeutics Initiates Phase 2a Study of Oral GLP-1 agonist GSBR-1290 for the Treatment of Type 2 Diabetes and Obesity
May 25, 2023 -
Business Wire
BenchSci Raises $95 Million Series D Funding to Enable Drug Discovery Innovation at Scale With its Groundbreaking AI Platform ASCEND
May 25, 2023 -
Accesswire
Protenus Granted New Patent for Drug Diversion Surveillance Technology
May 24, 2023 -
PR Newswire
FDA Approves AYVAKIT® (avapritinib) as the First and Only Treatment for Indolent Systemic Mastocytosis
May 22, 2023 -
Endpoints News
Comanche lines up trial for preeclampsia siRNA with Moderna, Medicines Company vets and GV backing
May 19, 2023 -
Globenewswire
Orchard Therapeutics Announces Positive Clinical and Preclinical Data in Programs Targeting Neurometabolic and CNS Disorders at ASGCT
May 19, 2023 -
PR Newswire
Insilico Medicine Successfully Explores the Advantages of Quantum Generative Adversarial Networks in Generative Chemistry
May 17, 2023 -
PR Newswire
Cadence Neuroscience Secures $26 Million in Series B Financing for Clinical Trials of Epilepsy Neuromodulation Therapy
May 17, 2023 -
News 12 - New Jersey
be Well: Howie Mandel talks about his OCD diagnosis and what led him to seek help
May 16, 2023 -
Newswire
Owkin Receives European Medicines Agency Letter of Support for Innovative AI-Driven Approach to Oncology Trial Analysis
May 16, 2023 -
Business Wire
Ensoma Closes Series B Extension, Bringing Total Round to $135 Million
May 16, 2023 -
Globenewswire
Cytek® Biosciences Marks Shipment of Its 100th Cell Sorter as the Company Continues to Lead Cell Analysis Forward
May 16, 2023 -
Business Wire
CHARM Therapeutics Receives Investment for Deep Learning-Enabled Drug Discovery Research from NVIDIA
May 15, 2023 -
PR Newswire
Rippl Appoints Industry Leading CEOs to Board Bringing Significant New Experience in Tech-enabled, Value-based Services and Senior-focused Mental and Behavioral Health
May 15, 2023 -
PR Newswire
Innovent Receives NMPA Breakthrough Designation for IBI351 (KRASG12C Inhibitor) as Monotherapy for Previously Treated Advanced Colorectal Carcinoma
May 14, 2023 -
PR Newswire
Comanche Biopharma Appoints Allyson Felix to Board of Directors
May 12, 2023 -
Globenewswire
UAE Biotech Insilico Medicine Offers Disease Modeling and Target Identification Course Using AI
May 12, 2023 -
Globenewswire
Avalyn Pharma Showcasing Therapeutic Approach and Clinical Status at ATS 2023 and the Respiratory Innovation Summit (RIS)
May 11, 2023 -
PR Newswire
Innovent Announces Phase 2 Clinical Study of Higher dose 9 mg Mazdutide (IBI362) in Chinese Adults with Obesity Achieved the 24-Week Primary Endpoint
May 10, 2023 -
Globenewswire
AI Drug Discovery Company Insilico Medicine Offers Free Course on Target Identification
May 10, 2023 -
PR Newswire
Doceree forms an exclusive partnership with Hello Health Group to strengthen its global footprint; forays into 8 South East Asian markets
May 10, 2023 -
Fierce Pharma
The most influential people in biopharma in 2023
May 9, 2023 -
Labiotech
Generative AI in novel drug development
May 2, 2023 -
Fierce Healthcare
Eleos Outreach brings AI-enabled click-to-text functionality to field-based clinicians’ EHRs
May 1, 2023 -
Fox News
Students use AI technology to find new brain tumor therapy targets — with a goal of fighting disease faster
May 1, 2023 -
Business Wire
Bicara Therapeutics Announces Oral Presentation of Head and Neck Cancer Dose Expansion Data from Phase 1/1b Study of BCA101 at Upcoming 2023 ASCO Annual Meeting
April 27, 2023 -
PR Newswire
Eleos Advances Behavioral Health AI with Breakthrough Offering for Field Providers
April 27, 2023 -
Globenewswire
Insilico Medicine Successfully Discovered Potent, Selective, and Orally Bioavailable Small Molecule Inhibitor of CDK8 Using Generative AI
April 24, 2023 -
Fierce Biotech
AppliedVR’s latest partnership expands covered access to VR therapeutics for veterans, active military
April 24, 2023 -
Business Wire
Bicara Therapeutics Announces Publication in Cancer Research Describing Design and Characterization of Lead Bifunctional Antibody Program, BCA101
April 19, 2023 -
Business Wire
Leyden Labs’ Intranasal PanFlu Antibody Enters the Clinic
April 19, 2023 -
PR Newswire
First-of-its-kind “Global Fertility at Work” Report from Carrot Fertility Reveals Financial Burden and Workplace Stigma are the Biggest Roadblocks to Accessing Fertility and Family-Forming Care
April 18, 2023 -
BBC News Services
How artificial intelligence is matching drugs to patients
April 17, 2023 -
BioPharma Dive
Biogen, aiming for a better Alzheimer’s therapy, licenses a Denali program
April 13, 2023 -
Globenewswire
Sana Biotechnology Announces Preclinical Data Published in Nature Communications Demonstrating the Ability of its Hypoimmune Allogeneic CD19-directed CAR T Cells to Evade Immune Rejection and Produce Durable Anti-Tumor Responses
April 13, 2023 -
Business Wire
Health Data Cloud Leader 1upHealth Raises $40 Million Series C led by Sixth Street Growth
April 13, 2023 -
Globenewswire
Insilico Medicine Successfully Discovered Potent, Selective, and Orally Bioavailable Small Molecule Inhibitor of CDK8 Using Generative AI
April 12, 2023 -
PR Newswire
AppliedVR Partners with Lovell to Better Serve Government Healthcare Systems
April 12, 2023 -
Business Insider
Devoted Health narrowed its losses in 2022, as rival insurance upstarts fought for survival. Now it’s adding members amid a big expansion.
April 11, 2023 -
Business Wire
Firefly Health Launches Advisory Council to Support Business Growth and Product Expansion
April 11, 2023 -
Business Wire
Rallybio Announces Clinical Proof-of-Concept Results for RLYB211, an Anti-HPA-1a Polyclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT), Published in the Journal of Thrombosis and Haemostasis
April 6, 2023 -
Business Wire
Bicara Therapeutics to Present Preclinical Data from Clinical-Stage Bifunctional Antibody Program, BCA101, at AACR Annual Meeting 2023
April 4, 2023 -
Authority Magazine
Health Tech: Jake Sattelmair Of Wellframe On How Their Technology Can Make An Important Impact On Our Overall Wellness
April 2, 2023 -
tech.eu
French AI biotech unicorn Owkin has launched a €33 million AI-powered precision medicine project for cancer diagnosis and treatment
March 31, 2023 -
Owkin
Owkin launches PortrAIt – a €33 million project to make France a global leader in using AI to diagnose and treat diseases
March 31, 2023 -
Home Health Care News
How Primary Care Startup Patina Locked Down Partnerships With 4 Big Health Plans
March 30, 2023 -
PR Newswire
Comanche Biopharma Announces FDA Clearance of Investigational New Drug (IND) Application for CBP-4888, an siRNA Investigational Therapy for the Treatment of Preeclampsia
March 30, 2023 -
Fierce Healthcare
Carrot Fertility expands benefits with hormone replacement therapy coverage
March 29, 2023 -
Boston Globe
Waltham biotech’s vision loss drug helps slow a form of macular degeneration
March 29, 2023 -
Business Wire
TandemAI Announces the Release of TandemViz™ 1.0 Web-based Graphical User Interface for Seamless Integration of Computational Analyses and Experimental Data
March 29, 2023 -
PR Newswire
Marshfield Clinic Health System and Notable Announce System-Wide Deployment of Intelligent Automation to Transform Patient and Staff Engagement
March 27, 2023 -
PR Newswire
AmplifyMD Announces SOC 2 Type 2 Compliance
March 27, 2023 -
Business Wire
Mental Health Leader SonderMind to Provide More Personalized Care with Acquisition of Mindstrong Technology
March 22, 2023 -
Chronicle
Making health care more accessible with technology
March 21, 2023 -
News Direct
Doceree takes the lead on transparency in programmatic Point-of-Care messaging by championing adoption of IAB standard
March 21, 2023 -
NY Post
AI develops cancer treatment in 30 days, predicts survival rate
March 21, 2023 -
PR Newswire
AppliedVR Becomes First Virtual Reality Provider to Receive HCPCS Level II Code from Centers for Medicare and Medicaid Services as Durable Medical Equipment
March 21, 2023 -
PR Newswire
Benchling Bolsters Success Offerings for Biotech R&D With New Purpose-Built Solutions, Training, and Expert Services
March 21, 2023 -
Business Wire
CHARM Therapeutics Announces Collaboration with Bristol Myers Squibb to Enable and Accelerate Small Molecule Drug Discovery Programs
March 20, 2023 -
Business Insider
We got the presentation health-tech veteran Jonathan Bush used to land $40 million for his new startup Zus Health
March 16, 2023 -
PR Newswire
Zus Health Closes Financing, Signs Partnership with Elation Health, to Accelerate Growth of its Data Service to Provide Connective Tissue for Healthcare
March 16, 2023 -
Business Wire
SpectrumAi Secures up to $20M Series A Investment
March 16, 2023 -
PR Newswire
Adela to present data demonstrating detection of multiple cancer types at the American Association for Cancer Research Annual Meeting 2023
March 14, 2023
The list includes investments made by funds managed by F-Prime. The companies are listed in alphabetical order. The list of investments is updated quarterly and, as such, may not reflect most recent F-Prime investments. This list also excludes companies that are currently in stealth.